Quick Search

 

 


 

 

Result Summary for 101468/003

Result Summary
Protocol ID: 101468/003
Clinical Study ID: 101468-003
Official Title: A single blind placebo controlled rising dose study of the effects of oral SK&F101468 (250 µg to 1000µg) on supine and erect blood pressure and plasma catecholamines in healthy male volunteers.
Phase: Phase 1
Study Indications or Diseases:
  • Parkinson Disease
Generic Name: ropinirole
Trade/Product Name: requip;requip
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.